Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to increase the efficiency of exposure in virtual reality (VR).

Based on the EMDR research the investigators would like to show that the implementation of eye movements during the VR exposure results in a faster physiological relaxation response among probands with spider phobia, which has a positive effect on the subjective and behavioral efficacy of the VR exposure.


Clinical Trial Description

The VR paradigm consists of one room with a spider in it. The proband is supposed to look at it for a few minutes. This exposure is repeated several times.

In the experimental group a ball appears during the exposure, that moves horizontally across the room. The probands are supposed to follow this movement with their eyes.

EDA, EKG and respiration are being recorded. Furthermore the subjective and behavioral spider phobia is measured before, during and after the exposure to determine occurring changes. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02973919
Study type Interventional
Source University of Regensburg
Contact
Status Completed
Phase N/A
Start date July 2015
Completion date September 2016

See also
  Status Clinical Trial Phase
Recruiting NCT04423783 - Gamification in the Treatment of Spider Phobia N/A
Completed NCT03410264 - One-session Treatment for Spider Fears N/A
Completed NCT04470882 - Use of Safety Behaviors in Exposure Therapy for Arachnophobia N/A